Literature DB >> 24381428

Changes in Serum PSA During Normal Menstrual Cycle.

Renu Nagar1, Abdulghani A Msalati2.   

Abstract

Prostate specific antigen (PSA) has long been used as a biological marker for prostatic cancer. Recent studies have demonstrated that PSA synthesis can be induced by steroid hormones in several tissues of women. Menstrual cycle is regulated by the cyclic variation of estradiol and progesterone. This study was undertaken in order to study the correlation of serum PSA to both these corpus luteal hormones. 110 serum samples and 10 saliva samples were collected from healthy women aged 18-45 years of age having normal menstrual cycles. Active PSA DSL-9700 ultrasensitive kit with detection limit 0.001 ng/ml was used to analyze PSA. 38.2 % of all serum samples and 10 % of saliva samples had detectable concentrations of PSA. The serum PSA was highest during mid follicular phase (between 4th and 8th days of cycle). Variation in PSA levels seemed to follow the variations in progesterone with a lag period of 12-14 days, but did not appear to bear any relationship with the estradiol levels.

Entities:  

Keywords:  Estradiol; IGF; IGFBP-3; Insulin like growth factor; Insulin like growth factor binding protein; PSA; Progesterone; Prostate specific antigen; Saliva; Serum

Year:  2012        PMID: 24381428      PMCID: PMC3547437          DOI: 10.1007/s12291-012-0263-2

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  23 in total

1.  Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.

Authors:  C Negri; F Tosi; R Dorizzi; A Fortunato; G G Spiazzi; M Muggeo; R Castello; P Moghetti
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

2.  Prostate-specific antigen in serum during the menstrual cycle.

Authors:  N Zarghami; L Grass; E R Sauter; E P Diamandis
Journal:  Clin Chem       Date:  1997-10       Impact factor: 8.327

3.  Hormonal oscillations during the estrous cycle influence the morphophysiology of the gerbil (Meriones unguiculatus) female prostate (skene paraurethral glands).

Authors:  Ricardo A Fochi; Ana P S Perez; Carlos V Bianchi; Sabrina S Rochel; Rejane M Góes; Patrícia S L Vilamaior; Sebastião R Taboga; Fernanda C A Santos
Journal:  Biol Reprod       Date:  2008-08-06       Impact factor: 4.285

4.  Biochemical characterization and immunolocalization of prostate-specific antigen in human term placenta.

Authors:  F Mannello; M Malatesta; E Fusco; G Bianchi; A Cardinali; G Gazzanelli
Journal:  Clin Chem       Date:  1998-08       Impact factor: 8.327

5.  Immunoreactivity of prostate-specific antigen in plasma and saliva of healthy women.

Authors:  F Mannello; G Bianchi; G Gazzanelli
Journal:  Clin Chem       Date:  1996-07       Impact factor: 8.327

6.  Changes of PSA concentrations in serum and saliva of healthy women during the menstrual cycle.

Authors:  Hülya Aksoy; Fatih Akçay; Zühal Umudum; A Kadir Yildirim; Ramazan Memisogullari
Journal:  Ann Clin Lab Sci       Date:  2002       Impact factor: 1.256

7.  Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.

Authors:  E M Rutanen; F Pekonen; T Mäkinen
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

8.  Measurement of serum ferritin by a 2-site immunoradiometric assay.

Authors:  L E Miles; D A Lipschitz; C P Bieber; J D Cook
Journal:  Anal Biochem       Date:  1974-09       Impact factor: 3.365

9.  Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry.

Authors:  J H van Krieken
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

10.  Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer.

Authors:  N Zarghami; L Grass; E P Diamandis
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  3 in total

1.  A Study on Omentin-1 and Prostate Specific Antigen in Women on Treatment for Polycystic Ovary Syndrome.

Authors:  Anbalagan Anithasri; Palghat Harihara Ananthanarayanan; P Veena
Journal:  Indian J Clin Biochem       Date:  2017-12-11

2.  Could Kallikrein-Related Serine Peptidase 3 Be an Early Biomarker of Environmental Exposure in Young Women?

Authors:  Salvatore Raimondo; Mariacira Gentile; Giusy Esposito; Tommaso Gentile; Ida Ferrara; Claudia Crescenzo; Mariangela Palmieri; Felice Cuomo; Stefania De Filippo; Gennaro Lettieri; Marina Piscopo; Luigi Montano
Journal:  Int J Environ Res Public Health       Date:  2021-08-21       Impact factor: 3.390

3.  Serum complexed and free prostate specific antigen levels are lower in female elite athletes in comparison to control women.

Authors:  Emma Eklund; Eleftherios P Diamandis; Carla Muytjens; Sarah Wheeler; Anu Mathew; Martin Stengelin; Eli Glezer; Galina Nikolenko; Marshall D Brown; Yingye Zheng; Angelica Lindén Hirschberg
Journal:  F1000Res       Date:  2017-07-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.